Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02985736 · ClinicalTrials.gov registry record · Phase 4
Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
A Phase 4 study, sponsored by Psoriasis Treatment Center of Central New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02985736 is a Phase 4 study that has completed, run by Psoriasis Treatment Center of Central New Jersey. The registered enrollment target is 20 participants.
The verdict
NCT02985736, a Phase 4 study, has completed, sponsored by Psoriasis Treatment Center of Central New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis
Interventions
- DRUG Topicort Topical Spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-01-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02985736
The ClinicalTrials.gov registry entry for NCT02985736 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Psoriasis Treatment Center of Central New Jersey, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topicort Topical Spray is the first listed.
NCT02985736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02985736 about?
NCT02985736 is a clinical study titled "Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray". A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis
What is the current status of trial NCT02985736?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2017-01-27.
What interventions are being tested in trial NCT02985736?
The interventions under investigation include: Topicort Topical Spray (DRUG).
Who is sponsoring clinical trial NCT02985736?
This trial is sponsored by Psoriasis Treatment Center of Central New Jersey, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.